Deepening Knowledge
Building on scientific evidence

Science · Innovation · People
A continuous journey. A brighter tomorrow.
From organ-specific cells to iPSCs: an overview of different cell technologies and their research context.
FOUR MILESTONES. A STRONGER TOMORROW.
Cell therapy has evolved significantly over the past decades, from organ-specific cells to induced pluripotent stem cells (iPSCs). Each milestone has expanded our understanding of biology and opened new possibilities for research and clinical application.
The 2000–2015 dates are technology-reference milestones, not Swiss Stem Cell founding or adoption dates, and not dates of first scientific discovery.
Cells from specific organs or tissues, studied in relation to tissue-specific functions.
A heterogeneous group of cells studied for differentiation and signalling properties.
Pluripotent cells derived from early embryos, with the capacity to form many specialised cell types.
Adult cells reprogrammed to a pluripotent state, opening possibilities for disease modelling and research.
MORE KNOWLEDGE. MORE POSSIBILITIES.
CONTINUING THE PURSUIT OF BETTER HEALTH.
As science advances, we remain committed to evidence-based research and responsible development in the field of regenerative medicine.
Building on scientific evidence
Advancing research and innovation
Through science, for future generations
Discreet. Personalised. Exceptional.
A healthier tomorrow
begins with a conversation.